Mehta Vimal (CIK 1733369) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy BTAI (219 shares), Buy BTAI (49,758 shares), Sell BTAI (19,419 shares), Buy BTAI (18,000 shares), Buy BTAI (164 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 219 | $0 |
| 2026-05-22 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 49,758 | $0 |
| 2026-05-22 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Sell | 19,419 | $21,108 |
| 2026-05-07 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 18,000 | $0 |
| 2026-03-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 164 | $0 |
| 2026-03-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 219 | $0 |
| 2025-12-15 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 164 | $0 |
| 2025-12-15 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 219 | $0 |
| 2025-09-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 163 | $0 |
| 2025-09-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 219 | $0 |
| 2025-07-22 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 15,625 | $0 |
| 2025-06-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 163 | $0 |
| 2025-06-16 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 219 | $0 |
| 2025-03-17 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 162 | $0 |
| 2025-03-17 | BioXcel Therapeutics, Inc. (BTAI) | CEO and President | Buy | 217 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17